Immune-Mediated Polyarthritis in Dogs: Welfare Management

Canine immune-mediated polyarthritis causes acute painful joint inflammation in dogs that responds well to immunosuppressive treatment when diagnosed promptly.

Key Facts

IMPA causes simultaneous inflammation of multiple joints from immune system dysfunction
Clinical signs include sudden onset lameness, fever, reluctance to move, and joint pain on palpation
Primary IMPA has no underlying cause; secondary IMPA is associated with infection or neoplasia
Treatment with prednisolone and sometimes additional immunosuppressants is highly effective
Breeds including Akitas, Boxers, Weimaraners, and Retrievers have increased prevalence

Welfare Considerations

Dogs with acute IMPA experience severe pain from multiple inflamed joints simultaneously, causing profound welfare impacts. Affected dogs may be unable to rise, walk, or adopt normal postures. Fever compounds the welfare burden. The condition appears to come on rapidly and can be mistaken for polytrauma. Prompt diagnosis and treatment with appropriate immunosuppression causes rapid welfare improvement, often within 48-72 hours. Long-term management requires monitoring for relapse and side effects of medication.

What You Can Do

Seek urgent veterinary assessment if your dog develops sudden severe lameness with fever
Complete the full course of immunosuppressive treatment as directed even if improvement is rapid
Discuss gradual dose reduction with your vet once remission is achieved
Monitor for relapse signs and seek prompt reassessment if they occur
Investigate for underlying conditions including infection and cancer in secondary IMPA cases